BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) shares fell 15% on Tuesday . The company traded as low as $0.3810 and last traded at $0.4064. 5,296,168 shares were traded during mid-day trading, a decline of 91% from the average session volume of 62,169,492 shares. The stock had previously closed at $0.4780.
BioRestorative Therapies Price Performance
The business’s fifty day simple moving average is $0.25 and its two-hundred day simple moving average is $0.67. The company has a market cap of $666.34 million, a PE ratio of -0.38 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc is a clinical‐stage regenerative medicine company focused on developing and commercializing advanced therapeutic platforms to promote tissue repair and healing. The company’s principal business activities are conducted through its wholly owned subsidiary, TissueForm, Inc, which holds the rights to a proprietary micro‐fiber scaffold technology designed to create a three‐dimensional matrix supporting cell migration, proliferation and new tissue formation. BioRestorative’s work is primarily targeted at chronic and non‐healing wounds, including diabetic foot ulcers and other complex soft‐tissue injuries.
The cornerstone of BioRestorative’s product pipeline is the TissueForm® line of scaffold materials.
Read More
- Five stocks we like better than BioRestorative Therapies
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
